These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 7748753

  • 21. Topical treatment of interdigital tinea pedis: terbinafine compared with clotrimazole.
    Patel A, Brookman SD, Bullen MU, Marley J, Ellis DH, Williams T, Barnetson RS.
    Australas J Dermatol; 1999 Nov; 40(4):197-200. PubMed ID: 10570555
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK, Gover MD, Lynde CW.
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [Abstract] [Full Text] [Related]

  • 24. Double-blind study of the efficacy of 1 week topical terbinafine cream compared to 4 weeks miconazole cream in patients with tinea pedis.
    Leenutaphong V, Niumpradit N, Tangwiwat S, Sritaveesuwan R, Muanprasat C.
    J Med Assoc Thai; 1999 Oct; 82(10):1006-10. PubMed ID: 10561963
    [Abstract] [Full Text] [Related]

  • 25. Combination treatment of oral terbinafine with topical terbinafine and 10% urea ointment in hyperkeratotic type tinea pedis.
    Shi TW, Zhang JA, Zhang XW, Yu HX, Tang YB, Yu JB.
    Mycoses; 2014 Sep; 57(9):560-4. PubMed ID: 24697872
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg/day vs. itraconazole 200 mg/day--a double-blind comparative trial.
    De Backer M, De Keyser P, De Vroey C, Lesaffre E.
    Br J Dermatol; 1996 Jun; 134 Suppl 46():16-7: discussion 38. PubMed ID: 8763462
    [Abstract] [Full Text] [Related]

  • 28. Efficacy, tolerability and consumer acceptability of terbinafine topical spray versus terbinafine topical solution: a phase IIa, randomised, observer-blind, comparative study.
    Brown M, Evans C, Muddle A, Turner R, Lim S, Reed J, Traynor M.
    Am J Clin Dermatol; 2013 Oct; 14(5):413-9. PubMed ID: 23740211
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group.
    Bräutigam M, Nolting S, Schopf RE, Weidinger G.
    BMJ; 1995 Oct 07; 311(7010):919-22. PubMed ID: 7580551
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Treatment outcome and relapse with short-term oral terbinafine (250 mg/day) in tinea pedis.
    Takiuchi I, Morishita N, Hamaguchi T, Ninomiya J, Higuchi R.
    Nihon Ishinkin Gakkai Zasshi; 2005 Oct 07; 46(4):285-9. PubMed ID: 16282972
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Treatment of chronic tinea pedis (athlete's foot type) with topical terbinafine.
    Savin RC.
    J Am Acad Dermatol; 1990 Oct 07; 23(4 Pt 2):786-9. PubMed ID: 2229524
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
    Arca E, Taştan HB, Akar A, Kurumlu Z, Gür AR.
    J Dermatolog Treat; 2002 Mar 07; 13(1):3-9. PubMed ID: 12006131
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.